5-Star Stocks Poised to Pop: Becton Dickinson

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, medical-device maker Becton, Dickinson and Co. (NYSE: BDX  ) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at BD's business and see what CAPS investors are saying about the stock right now.

BD facts

Headquarters (founded) Franklin Lakes, N.J. (1897)
Market Cap $16.3 billion
Industry Healthcare equipment
Trailing-12-Month Revenue $7.9 billion
Management CEO Vincent Forlenza (since October 2011)
CFO David Elkins (since December 2008)
Return on Capital (average, past 3 years) 14.4%
Cash/Debt $2.7 billion / $4.2 billion
Dividend Yield 2.3%
Competitors Abbott Labs
Baxter International
Covidien

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 98% of the 1,146 members who have rated BD believe the stock will outperform the S&P 500 going forward.

A couple of months ago, one of those Fools, All-Star msIRA, listed several of BD's positives:

Stable business. Good [return on equity]. Good profit margins. Fairly valued. Good long term growth rate. Plus if the market corrects this will outpermform short term I would guess. And outperform long term also.

If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite its five-star rating, Becton, Dickinson and Co. may not be your top choice.

We've found another stock we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2012." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the new TrackPoisedTo CAPS account.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Motley Fool newsletter services have recommended buying shares of Becton, Dickinson and Covidien. The Fool owns shares of Abbott. Try any of our Foolish newsletter services free for 30 days.

We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1877164, ~/Articles/ArticleHandler.aspx, 11/24/2014 4:37:57 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement